Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 68-75

  Miller, Karen K ^b   Daly, Patricia A ^b   Sentochnik, Deborah ^b   Doweiko, John ^b   Samore, Matthew ^b   Basgoz, Nesli O ^b   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; HYDROCORTISONE; INDINAVIR; LAMIVUDINE; LORATADINE; PROTEINASE INHIBITOR; RANITIDINE; STAVUDINE; TETRACYCLINE; YOHIMBINE; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CUSHING SYNDROME; CUSHINGOID SYNDROME; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE URINE LEVEL; IMMUNE FUNCTION TEST; LABORATORY TEST; MALE; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUBCUTANEOUS FAT DISORDER; WEIGHT GAIN;

EID: 0031829526     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514638     Document Type: Article

References (30)

1. Smals AGH, Njo KT, Knoben JM, Ruland CM, Kloppenborg PWC. Alcohol-induced Cushingoid syndrome. J R Coll Physicians Lond 1977;12:36-41.
2. Rees LH, Besser GM, Jeffcoate WJ, Goldie EJ, Marks V. Alcohol-induced pseudo-Cushing's syndrome. Lancet 1977;1:726-8.
3. Kirkman S, Nelson DH. Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism 1988;37:390-4.
4. Lamberts SWJ, Klijn JGM, de Jong FH, Birkenhager JC. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. JAMA 1979;242:1640-3.
5. Schlechte JA, Sherman B, Pfohl B. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease. Horm Res 1986;23:1-8.
6. Carroll BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 1981;38:15-22.
7. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992;327:1360-5.
8. Verges B, Chavanet P, Desgres J, et al. Adrenal function in HIV-infected patients. Acta Endocrinol (Copenh) 1989;121:633-7.
9. Villette JM, Bourin P, Doinel C, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990;70:572-7.
10. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987;65:482-7.
11. Hilton CW, Harrington PT, Prasad C, Svec F. Adrenal insufficiency in the acquired immunodeficiency syndrome. South Med J 1988;81:1493-5.
12. Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez E. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992;5:841-6.
13. Biglino A, Limone P, Forno B, et al. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur J Endocrinol 1995;133:173-9.
14. Orth DN. Cushing's syndrome. N Engl J Med 1995;332:791-803.
15. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434-44.
16. Yanovski JA, Cutler GB, Chrousos GP, Nieman LK. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: a new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993;269:2232-8.
17. Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 1997;26:741-62.
18. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megesterol acetate in patients with AIDS. Ann Intern Med 1995;122:843-5.
19. Azar S, Melby J. Hypothalamic-pituitary-adrenal function in non-AIDS patients with advanced HIV infection. Am J Med Sci 1993;305:321-5.
20. Lortholary O, Christeff N, Casassus P, et al. Hypothalamo-pituitary-adrenal function in human immunodeficiency virus-infected men. J Clin Endocrinol Metab 1996;81:791-6.
21. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985;60:947-52.
22. Eagling VA, Back DJ, Barry MG. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol 1997;44:190-4.
23. Kino T, Kopp JB, Chrousos GP. The HIV-1 VPR gene product enhances the transactivating effects of glucocorticoids in human lymphoid and muscle-derived cell lines. The Endocrine Society program and abstracts: 79th annual meeting (Minneapolis). Bethesda, MD: Endocrine Society Press, 1997:13.
24. Christeff N, Michon C, Goertz G, et al. Abnormal free fatty acids and cortisol concentrations in the serum of AIDS patients. Eur J Cancer Clin Oncol 1988;24:1179-83.
25. Klein A, Bruser B, Robinson JB, Pinkerton PH, Malkin A. Effect of a non-viral fraction of acquired immunodeficiency syndrome plasma on the vulnerability of lymphocytes to cortisol. J Endocrinol 1987;112:259-64.
26. Vallette G, Sumida C, Thobie N, Nunez EA. Modulation of glucocorticoid binding to rat liver cytosol receptor by lipid-soluble extracts from the serum of AIDS patients. AIDS Res Hum Retroviruses 1992;8:1693-7.
27. Nunez EA, Christeff N, Benassayag C, Martin ME, Vallette G. Corticosteroid modifications in HIV infection: a role for nonesterified fatty acids. AIDS Res Human Retroviruses 1990;6:1147-8.
28. Grunfeld C, Kotler DP, Hamadeh R, Tiemey A, Wang J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.
29. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-52.
30. Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993;76:559-65.